iBio Inc. (IBIO)
IBIO trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$0.7818
-13.44% on the day
Market cap
$50.3M
Micro cap
Revenue · 2025
$400K
+77.8% on 2024
Net income · 2025
-$18.4M
-4595.0% net margin
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC XBRL frames, calendar 2025.
Profile
| Field | Value |
|---|---|
| Ticker | IBIO on Nasdaq |
| Sector | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Country | United States |
| IPO year | Not reported by the screener |
| SEC CIK | 0001420720 |
| SEC industry code | Pharmaceutical Preparations |
| Incorporated in | DE |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $400K |
| Net income | -$18.4M |
| Operating income | -$18.6M |
| Net margin | -4595.0% |
| Operating margin | -4650.5% |
| Revenue growth | +77.8% |
| Cash | $28.7M |
| Total assets | $64.4M |
| P/E (computed) | Net income was not positive |
| P/S (computed) | 125.7× |
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | 424B3 | 2026-04-29 |
| Latest annual report | 10-K | 2026-08-28 |
| Latest quarterly / interim | 10-Q | 2026-05-12 |
| Latest current report | 8-K | 2026-10-13 |
| Latest proxy | DEF 14A | 2026-09-04 |
Source: SEC EDGAR submissions feed, 902 recent filings. All filings on EDGAR.
Peers in Biotechnology: Pharmaceutical Preparations
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| MREO | Mereo BioPharma Group plc | $0.3200 | +1.52% | $51.1M |
| HYPD | Hyperion DeFi Inc. | $3.36 | -3.17% | $51.9M |
| ATHE | Alterity Therapeutics Limited | $2.85 | -2.73% | $51.9M |
| RNXT | RenovoRx Inc. | $1.15 | -8.00% | $51.9M |
| CLNN | Clene Inc. | $3.39 | -7.88% | $48.2M |
| HOWL | Werewolf Therapeutics Inc. | $0.9911 | +0.95% | $48.2M |
| ELTX | Elicio Therapeutics Inc. | $1.77 | -5.85% | $48.0M |
| ACET | Adicet Bio Inc. | $5.11 | -7.59% | $47.8M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier